Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Geistlich Pharma hails business success in 2012

Geistlich Pharma hails business success in 2012

16th January 2013

Geistlich Pharma has expressed satisfaction with its performance during 2012, a year that saw the company achieve a strong rate of growth despite negative wider economic trends.

A report from the Swiss firm has noted that it was able overcome poor conditions in its main market of Europe through the launch of innovative products and a proactive approach to geographic expansion.

In the last 12 months, the company introduced its new Geistlich Bio-Oss Pen in Europe to an extremely positive market response and has invested in research across its biomaterials, surgery and medical divisions.

Moreover, it commenced the sale of its bone substitute material Geistlich Bio-Oss in Japan last year, while a subsidiary division was established in North America to complement its existing operations in South Korea, Brazil, France, China, the UK, Germany and Italy.

The company said: "This strategy of a balanced geographical mix and new products based on Geistlich Pharma's expertise in the field of regeneration will be continued by the company in 2013."

Geistlich Pharma's corporate history dates back to 1851 and serves customers in more than 50 countries.ADNFCR-8000103-ID-801523649-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.